Appendix Table 1.
Allele copy numbers defining each SNP combination and metabolizer category | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP | Fast | Intermediate | Slow | Not categorizeda | ||||||||
Ordinal level of EFV metabolismb (1 = fastest, 10 = slowest) | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | — | — |
rs3745274 (516G>T) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 1 |
rs28399499 (983T>C) | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 2 | 0 | 1 |
rs4803419 (15582C>T) | 0 | 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 1 |
No. of participants in whole study by SNP combination | 206 | 45 | 6 | 249 | 59 | 43 | 2 | 91 | 42 | 1 | 1 | 1 |
No. of participants in final cohort by SNP combination | 69 | 9 | 2 | 77 | 22 | 18 | 0 | 30 | 14 | 0 | 1c | 0d |
Two SNP combinations were unable to be categorized as fast, intermediate, or slow based on the previously published pharmacokinetic framework,10 and metabolizer strata were imputed for these SNP combinations.
Based on previously published pharmacokinetic modeling study by Holzinger et al.9
Imputed as intermediate metabolize.
Imputed as slow metabolizer.
SNP, single-nucleotide polymorphism.